Next Article in Journal
Quality-by-Design Based Characterization of Pharmaceutical Processes by Means of Numerical Simulations
Previous Article in Journal
HS-SPME-GCMS Method Development for Sensitive Diisopropylphenol Analysis Suited for Adsorption/Absorption Studies and Cleaning Validations
Article Menu

Article Versions

Export Article

Open AccessConference Report
Sci. Pharm. 2010, 78(3), 699; doi:10.3797/scipharm.cespt.8.PPAT10

Use of Forced Degradation Studies on S-(−)-Amlodipine Besylate to Generate Information on the Degradation Products

1
Agency for Medicinal Products and Medical Devices of B&H, 71000 Sarajevo, Bosnia and Herzegovina
2
National Research Centre, Tahrir Street, Cairo, Egypt
*
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Download PDF [179 KB, uploaded 11 October 2016]

Abstract

Amlodipine is a long-acting calcium channel blocker used in the treatment of hypertension and angina pectoris. [...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

HADŽIDEDIĆ, Š.; UZUNOVIĆ, A.; PILIPOVIĆ, S.; KOCOVA EL-ARINO, S. Use of Forced Degradation Studies on S-(−)-Amlodipine Besylate to Generate Information on the Degradation Products. Sci. Pharm. 2010, 78, 699.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top